Verification and validation of the anti-PD-L1 antibody, Clone 22C3 on a laboratory-developed test
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Pathology"
DOI: 10.1136/jclinpath-2022-208353
Abstract: Aims The first aim of this study is to compare and validate the performance of the programmed death receptor ligand 1 (PD-L1) IHC 22C3 pharmDx assay kit processed via Dako Omnis platform with the Dako… read more here.
Keywords: agreement; laboratory developed; pathology; dako omnis ... See more keywords